Your session is about to expire
← Back to Search
Weighted Blankets for Pediatric Cancer Anxiety
N/A
Waitlist Available
Led By Jennifer Olson
Research Sponsored by University of Colorado, Denver
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Newly diagnosed pediatric oncology patients between the ages of 4 and 17 receiving outpatient chemotherapy infusions in designated locations (Anschutz Campus and Colorado Springs Hospital)
Patients with a 'liquid tumor' (leukemia or lymphoma), 'solid tumor', or a neuro-oncologic diagnosis
Must not have
Patients undergoing bone marrow transplant or had a previous bone marrow transplant
Patients who start initial chemotherapy infusions in the outpatient setting
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights
No Placebo-Only Group
Summary
This trial found that among pediatric cancer patients, the use of a weighted blanket may help to decrease anxiety during treatment.
Who is the study for?
This trial is for pediatric oncology patients aged 4-17, who weigh over 13.5kg and are receiving outpatient chemotherapy at specific locations. It's for those with leukemia, lymphoma, solid tumors or neuro-oncologic diagnoses who haven't used weighted blankets before and can complete certain assessments in English or Spanish.
What is being tested?
The study is testing if using weighted blankets reduces anxiety in children with cancer during their therapy sessions. The focus is on kids getting outpatient chemo treatments to see how these blankets might improve their mental well-being.
What are the potential side effects?
Since the intervention involves non-medical items (weighted blankets), there are no direct medical side effects expected from this trial. However, comfort levels may vary individually when using the blanket.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am a child aged 4-17 with cancer, starting chemotherapy at specific hospitals.
Select...
I have leukemia, lymphoma, a solid tumor, or a brain/spinal cord cancer.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I am undergoing or have had a bone marrow transplant.
Select...
I started my chemotherapy as an outpatient.
Select...
I am either younger than 4 or older than 17 years old.
Select...
My condition has worsened after initial improvement.
Select...
I am currently hospitalized.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Children's Anxiety Meter-State (CAM-S) assessment
Secondary study objectives
Pediatric Quality of Life Inventory Generic Core Scales (Peds QL 4.0)
Other study objectives
Weighted Blanket Use
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Active Control
Group I: WB:UCActive Control1 Intervention
Weighted Blanket 2nd infusion Usual Care 3rd infusion
Group II: UC:WBActive Control1 Intervention
Usual Care 2nd infusion Weighted Blanket 3rd infusion
Find a Location
Who is running the clinical trial?
University of Colorado, DenverLead Sponsor
1,805 Previous Clinical Trials
2,822,320 Total Patients Enrolled
Children's Hospital ColoradoOTHER
120 Previous Clinical Trials
5,133,165 Total Patients Enrolled
Jennifer OlsonPrincipal InvestigatorChildren's Hospital Colorado
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I can speak English and Spanish.I am undergoing or have had a bone marrow transplant.I started my chemotherapy as an outpatient.I weigh more than 13.5kg.I am a child aged 4-17 with cancer, starting chemotherapy at specific hospitals.My second and third chemotherapy sessions were less than 30 days apart.I am either younger than 4 or older than 17 years old.My condition has worsened after initial improvement.I have leukemia, lymphoma, a solid tumor, or a brain/spinal cord cancer.I am currently hospitalized.
Research Study Groups:
This trial has the following groups:- Group 1: WB:UC
- Group 2: UC:WB
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger